As a triple agonist , it simultaneously activates three distinct receptor systems [5]: GIP (Glucose-dependent Insulinotropic Polypeptide) receptors enhance insulin secretion and may have direct effects on adipose tissue GLP-1 (Glucagon-like Peptide-1) receptors promote satiety, slow gastric emptying, and improve glucose regulation Glucagon receptors increase energy expenditure and may enhance fat oxidation This multi-receptor targeting strategy distinguishes retatrutide from single-pathway peptides and creates a complex metabolic profile that researchers are still working to fully characterize
Beyond cardiovascular outcomes, women showed meaningful protective effects, including approximately 50% lower rates of ovarian cancer incidence, 14% lower breast cancer incidence and 16% reductions in osteoporosis compared to female non-users
Together, these changes may reduce the metabolic strain that can interfere with healthy insulin function and blood sugar regulation
When you stop taking semaglutide, youre no longer providing your body with the medication thats been boosting your natural GLP-1s effects
Three commitment tiers allow you to select the plan that works best for your treatment timeline, with pricing ranging across options designed to support long-term adherence